Industrial bioprocessing market seen reaching $29.05 billion by 2030

The Industrial Bioprocessing Global Market Report 2026 forecasts steady growth through 2030, driven by biologics demand, biomanufacturing scale-up and sustainable production goals. North America led the market in 2025, while Asia-Pacific is expected to grow the fastest.

Why it matters: - Industrial bioprocessing is becoming a core manufacturing method for biologics, enzymes, bio-based chemicals and fuels. - The market outlook points to rising demand for cleaner, more scalable production across pharmaceuticals and industrial applications. - Growth in this sector also reflects broader pressure to make manufacturing more sustainable and cost-effective.

What happened: - The Business Research Company published its Industrial Bioprocessing Global Market Report 2026, covering market size, trends and forecasts for 2026-2035. - The report estimates the market will grow from $18.95 billion in 2025 to $20.61 billion in 2026. - The report projects the market will reach $29.05 billion by 2030. - The forecast implies a 9.0% CAGR from 2026 to 2030.

The details: - Recent growth has been driven by pharmaceutical manufacturing demand, industrial enzyme production, fermentation-based technologies, biotechnology research investments and large-scale biomanufacturing infrastructure. - Future growth is expected to come from demand for bio-based chemicals and fuels, precision medicine, biologics manufacturing, cost-effective biomanufacturing, advanced cell culture technologies and sustainable industrial production. - The report highlights single-use bioprocessing systems, downstream purification technologies, larger fermentation capacity, modular bioreactor designs and regulatory-compliant production as key trends. - Industrial bioprocessing uses microorganisms, enzymes or living cells to run controlled biological reactions at commercial scale. - The process combines biotechnology, process engineering and real-time monitoring to improve efficiency, consistency and sustainability. - North America held the largest market share in 2025. - Asia-Pacific is expected to post the fastest growth during the forecast period. - The report also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - The 2026 report adds market attractiveness scoring, TAM analysis, company scoring matrices, Excel dashboards, market hotspots infographics, and updated graphics and tables.

Between the lines: - The report frames industrial bioprocessing as part of the shift from traditional chemical manufacturing toward biologically derived production. - The biosimilars data cited in the release signals stronger downstream demand for the cell-culture and fermentation capacity that industrial bioprocessing provides. - The regional split suggests mature demand in North America and faster capacity buildout in Asia-Pacific.

What's next: - The market is expected to keep expanding as biologics, biosimilars and sustainable production methods gain share. - Companies are likely to focus on contamination control, purification efficiency and flexible bioreactor systems as they scale production. - The Business Research Company is promoting access to the full report and a free sample through its website the full report and a free sample.

The bottom line: - Industrial bioprocessing is moving from niche technique to mainstream industrial platform, with strong growth tied to biologics, sustainability and large-scale biomanufacturing.